SE8008713L - 1-(bensazolylalkyl)piperidiner - Google Patents

1-(bensazolylalkyl)piperidiner

Info

Publication number
SE8008713L
SE8008713L SE8008713A SE8008713A SE8008713L SE 8008713 L SE8008713 L SE 8008713L SE 8008713 A SE8008713 A SE 8008713A SE 8008713 A SE8008713 A SE 8008713A SE 8008713 L SE8008713 L SE 8008713L
Authority
SE
Sweden
Prior art keywords
formula
lower alkyl
compound
van
preparation
Prior art date
Application number
SE8008713A
Other languages
English (en)
Other versions
SE435621B (sv
Inventor
J Vandenberk
L E J Kennis
Der Aa M J M C Van
Heertum A H M Th Van
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/687,139 external-priority patent/US4066772A/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SE8008713L publication Critical patent/SE8008713L/sv
Publication of SE435621B publication Critical patent/SE435621B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Claims (2)

Pat entkrav. 1. Farfarande for framstallning av en kemisk fOrening corn gares av ett 1-(bensazolylalkyl)piperidinderivat med fox-main; (I-h) eller c) an Torening'med formeln R3 N7,1-(CHdin-C1-1-(CHz)n-N A (V ) ut- I2 R R• och farmaceutiskt godtagbara syraadditionssalter darav, Vari RI och R2 var far sig betecknar vate, halo, lagalkyl eller trifluorometyl; 9 o betecknar en tvavard grupp corn utgares an -N(L)-C-, -NH-C-, -S-C-, 9 -0-c-, -NN- eller -NCH-, .varvid L betecknar vEte, lagalkyl, lagalkylkarbonyl eller lagalkenyl, och de tvavarda grupperna Or bUndna till bensenkarnan via heteroatomen; R3 betecknar vate elleigyl; r m och n vardea beteck,tt tal fran11 2; och
1. (I-c) il van i B2 betecknar iiiiC(0)-, -NH-C ' l'- eller -NCH-, - 0th, on a Onskas,111,maceutiskt ggbara syraadditionssalt fram- stalles an produkterna fin stegen (1-a) till (I-c). ringslutes med ett lampligt cykliseringsmedel enligt kanda metoder for framstallning av en farening med formeln N3 -y—N N-(Cliz)m-LH-(C1-12.).-N\_.! gruppen -N A utgOres av en grupp med formeln 0 -R4 -N R R6 van i R4 betecknar vate eller lagalkyl; och och 6 var fbr sig betecknar vate, halo, lagalkyl eller trifluorometyl; kanneteckoat av att a) en fOrening med formeln 3 B van i 31 bar samma'betydelse eon B men ej -NH-C(S)-, och X Sr en lamp-hg reaktiv esterfunktion harledd fran motsvarande alkohol, bringas att reagera med en fOrening med formeln ett lampligt organiskt losningsmedel, rdrframstgllning av en fore-fling med formeln RI 3 BN -(C14 )NA
2. rn (1-a ) •
SE8008713A 1975-07-21 1980-12-11 Analogiforfarande for framstellning av 1-(bensimidazolylalkyl)piperidiner SE435621B (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US59779375A 1975-07-21 1975-07-21
US05/687,139 US4066772A (en) 1975-07-21 1976-05-17 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds
KR7601697A KR810000334B1 (ko) 1975-07-21 1976-07-12 1-(벤즈 아조릴알킬) 피페리딘 유도체의 제조방법

Publications (2)

Publication Number Publication Date
SE8008713L true SE8008713L (sv) 1980-12-11
SE435621B SE435621B (sv) 1984-10-08

Family

ID=27348142

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7608265A SE426490B (sv) 1975-07-21 1976-07-20 Analogiforfarande for framstellning av 1-(bensazolylalkyl)piperidiner
SE8008713A SE435621B (sv) 1975-07-21 1980-12-11 Analogiforfarande for framstellning av 1-(bensimidazolylalkyl)piperidiner

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7608265A SE426490B (sv) 1975-07-21 1976-07-20 Analogiforfarande for framstellning av 1-(bensazolylalkyl)piperidiner

Country Status (25)

Country Link
JP (1) JPS5217475A (sv)
AT (1) AT364358B (sv)
AU (1) AU511027B2 (sv)
BG (1) BG26526A3 (sv)
CA (1) CA1085852A (sv)
CH (1) CH623820A5 (sv)
CS (1) CS202550B2 (sv)
DE (1) DE2632870A1 (sv)
DK (1) DK154950C (sv)
ES (3) ES449740A1 (sv)
FI (1) FI62667C (sv)
GB (1) GB1542514A (sv)
HK (1) HK14180A (sv)
IE (1) IE43496B1 (sv)
IT (1) IT1062614B (sv)
KE (1) KE3215A (sv)
LU (1) LU75354A1 (sv)
MY (1) MY8100017A (sv)
NL (1) NL187442C (sv)
NZ (1) NZ181256A (sv)
PH (1) PH13710A (sv)
PT (1) PT65387B (sv)
RO (1) RO70566A (sv)
SE (2) SE426490B (sv)
YU (1) YU39969B (sv)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4501749A (en) * 1983-10-31 1985-02-26 Merck & Co., Inc. Peripherally selective dopamine antagonists in the treatment of ocular hypertension
JPS6248684A (ja) * 1985-08-26 1987-03-03 Sumitomo Chem Co Ltd 新規なヨ−ドブチロフエノン誘導体およびその製造法
JPS62251313A (ja) * 1986-04-25 1987-11-02 信越ポリマー株式会社 結束装置
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
US6355659B1 (en) 1994-07-29 2002-03-12 Laboratorios Del Dr. Esteve, S.A. 4-(4-Chlorophenyl)-1236-tetrahydro-1(1H-124-triazol-1-yl)butty)pyrideine and salts thereof; pharmaceutical compositions and method of treating psychoses utilizing same
JO2785B1 (en) * 2003-05-27 2014-03-15 شركة جانسين فارماسوتيكا ان. في Quinazoline derivatives
DE602004012891T2 (de) 2003-12-18 2009-04-09 Janssen Pharmaceutica N.V. Pyrido- und pyrimidopyrimidinderivate als anti-proliferative mittel
NI200700147A (es) 2004-12-08 2019-05-10 Janssen Pharmaceutica Nv Derivados de quinazolina inhibidores de cinasas dirigidos a multip
BRPI0714211B8 (pt) 2006-07-13 2021-05-25 Janssen Pharmaceutica Nv derivados de mtki quinazolina, sua utilização e composição farmacêutica que os compreende
EP1997805A1 (en) * 2007-06-01 2008-12-03 Commissariat à l'Energie Atomique Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
JP5536647B2 (ja) 2007-07-27 2014-07-02 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピロロピリミジン
ES2593706T3 (es) 2007-08-31 2016-12-12 Purdue Pharma Lp Compuestos de piperidina, de tipo quinoxalina sustituida, y usos de los mismos
US9090618B2 (en) 2012-12-27 2015-07-28 Purdue Pharma L.P. Substituted benzimidazole-type piperidine compounds and uses thereof
CN113995755A (zh) * 2016-02-04 2022-02-01 辛多美制药有限公司 氘代多潘立酮组合物和用于治疗病症的方法
US11364226B2 (en) 2017-06-30 2022-06-21 Cinrx Pharma, Llc Deuterated domperidone compositions, methods, and preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE633495A (sv) * 1962-06-13
BE633914A (sv) * 1962-06-22
US3629267A (en) * 1968-10-28 1971-12-21 Smith Kline French Lab Benzoheterocyclicalkyl derivatives of 4-(2-keto -1-benzimidazolinyl)-piperidine 4-(2-keto - 1 - benzimidazolinyl) -1 2 3 6 tetrahydropyridine 1 - phenyl - 1 3 8-triazaspiro(4 5)decan - 4 - one and 2 4 9-triazaspiro(5 5)undecan-1 3 5-trione
AU4698672A (en) * 1972-09-22 1972-11-09 Ciba-Geigy Ag Azacycloaliphatic compounds, process for their manufacture and compositions containing them
FR2218100A1 (en) * 1973-02-20 1974-09-13 Janssen Pharmaceutica Nv Neuroleptic tricyclic derivs. - of benzimidazolinones and triazaspiro-4,5-decan-4-ones
US3989707A (en) * 1974-06-21 1976-11-02 Janssen Pharmaceutica N.V. Benzimidazolinone derivatives

Also Published As

Publication number Publication date
GB1542514A (en) 1979-03-21
AU511027B2 (en) 1980-07-24
YU39969B (en) 1985-06-30
PH13710A (en) 1980-09-09
JPS5217475A (en) 1977-02-09
LU75354A1 (sv) 1977-02-28
CA1085852A (en) 1980-09-16
SE426490B (sv) 1983-01-24
SE435621B (sv) 1984-10-08
NZ181256A (en) 1978-04-28
CS202550B2 (en) 1981-01-30
YU179476A (en) 1983-01-21
DE2632870C2 (sv) 1989-02-16
ES461631A1 (es) 1978-12-01
IE43496B1 (en) 1981-03-11
FI62667B (fi) 1982-10-29
FI762086A (sv) 1977-01-22
NL187442B (nl) 1991-05-01
ATA534776A (de) 1981-03-15
BG26526A3 (sv) 1979-04-12
MY8100017A (en) 1981-12-31
AU1596476A (en) 1978-01-19
JPS6131109B2 (sv) 1986-07-17
AT364358B (de) 1981-10-12
FI62667C (fi) 1983-02-10
DK154950B (da) 1989-01-09
DK154950C (da) 1989-05-29
PT65387B (en) 1978-06-09
PT65387A (en) 1976-08-01
DE2632870A1 (de) 1977-02-10
ES461630A1 (es) 1978-06-16
IT1062614B (it) 1984-10-20
IE43496L (en) 1977-01-21
KE3215A (en) 1982-07-09
ES449740A1 (es) 1978-02-16
RO70566A (ro) 1982-10-11
SE7608265L (sv) 1977-01-22
DK327576A (da) 1977-01-22
CH623820A5 (en) 1981-06-30
HK14180A (en) 1980-03-28
NL187442C (nl) 1991-10-01
NL7608023A (nl) 1977-01-25

Similar Documents

Publication Publication Date Title
SE8008713L (sv) 1-(bensazolylalkyl)piperidiner
PT88410A (pt) Process for preparing thiazolidinedione derivatives
GB1014053A (en) 7-hydroxy-coumarin derivatives and process for their production
ES417791A1 (es) Procedimiento para la produccion de preparados activos so- bre el metabolismo que contienen acido 4 - hidroxi -3,5 - alcohil-fenil - propionico.
ES443912A1 (es) Procedimiento para preparar derivados del acido fenil-aceti-co.
GB1212460A (en) Naphthacene derivatives
ES485650A1 (es) Procedimiento para la preparacion de 1,2,3-tiadiazol-5-il- ureas
ES256994A1 (es) Procedimiento para la preparaciën de derivados de dibenzocicloheptano terapeuticamente activos
ATE48994T1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
ATE42295T1 (de) Penem-derivate, verfahren zu deren herstellung, ihre verwendung und pharmazeutische zusammensetzungen.
ES464013A1 (es) Procedimiento para preparar derivados sustituidos de orto- fenilendiamina.
GB824536A (en) Improvements in or relating to new phenthiazine derivatives and processes for their preparation
ES8106714A1 (es) Procedimiento de preparar derivados 1,2,4-oxadiacinicos
GB871235A (en) Novel substituted pyrrolidones and salts thereof and a process for the manufacture of same
GB823338A (en) Diquaternary salts of aminoalkyl piperidines
GB899385A (en) Improvements in or relating to new hydrazine derivatives and process for their preparation
ES441965A1 (es) Un procedimiento para la preparacion de nuevos derivados de 7-oxo-4-oxa-1-aza-biciclo (3, 2, 0) heptano.
JPS5470278A (en) Indolinethione derivatives
TH4776EX (th) อนุพันธ์ควิโนลีนชนิดใหม่และกรรมวิธีสำหรับการเตรียมของสารนั้น
GB815968A (en) New dioxolane derivatives and process for their preparation
GB764690A (en) New sensitizing dyestuffs of the merocyanine series and their manufacture and use
GB1012619A (en) Improvements in or relating to dibenzocyclohepta-diene and -triene derivatives
GB1374344A (en) Pharmaceutically active nitrosourea derivatives
GB770624A (en) Substituted endoxy-perhydroisoindolines
ES306443A1 (es) Procedimiento de preparaciën de derivados de quinoleina

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8008713-3

Effective date: 19930204

Format of ref document f/p: F